$ITMN Recent News 6 stocks to watch 3:25 p.m. May 29,

New Post Public Reply Private Reply Replies (0) Message Board

Jun 3, 2014 at 9:34 AM

$ITMN Recent News

6 stocks to watch 3:25 p.m. May 29, 2014 - The Trading Deck
Charting the Nasdaq’s technical breakout 12:34 p.m. May 27, 2014 - Michael Ashbaugh
Charting the Nasdaq’s technical breakout 12:05 p.m. May 27, 2014 - Michael Ashbaugh
6 stocks to watch 3:25 p.m. May 7, 2014 - The Trading Deck
InterMune slips off lofty perch while Aegerion's earnings disappoint 12:26 p.m. Feb. 26, 2014 - Russ Britt
'Bad' weather heads west, retailers report, and don't short addiction 8:06 a.m. Feb. 26, 2014 - Shawn Langlois
InterMune's big day lifts ETF, biotech index to record highs 5:44 p.m. Feb. 25, 2014 - Russ Britt
InterMune shares more than double on tests for lung-disease treatment 12:27 p.m. Feb. 25, 2014 - Russ Britt
Biogen, InterMune, Alkermes all make stock waves with earnings 2:28 p.m. July 25, 2013 - Russ Britt
Hedge funds are buying these stocks 4:41 p.m. April 26, 2013 - Insider Monkey
Market post-mortem: Big biotechs spike as Street warming to firms 5:43 p.m. April 12, 2013 - Russ Britt
InterMune shares jump after U.K. regulator recommends key drug 10:44 a.m. March 21, 2013 - Russ Britt
Thursday’s biggest movers; Apple at 5-month low 6:27 p.m. Nov. 8, 2012 - Sue Chang
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Stocks to watch Tuesday: Nordson, Georgia Gulf 6:40 a.m. May 22, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 4:19 p.m. April 9, 2012 - Kate Gibson
InterMune: Light at the end of the tunnel? 3:31 p.m. April 9, 2012 - blogs.marketwatch.com
InterMune tumbles on study update 12:27 p.m. April 9, 2012 - Val Brickates Kennedy
Thursday’s biggest gaining & declining stocks 4:34 p.m. March 15, 2012 - Kate Gibson
InterMune climbs on German regulatory update 12:28 p.m. March 15, 2012 - Val Brickates Kennedy

InterMune Resubmits Esbriet NDA - Analyst Blog 6:18 p.m. May 28, 2014 - Zacks.com
Isis Shines, PTC Therapeutics Soars - Analyst Blog 11:16 a.m. May 28, 2014 - Zacks.com
Intermune resubmits NDA 8:24 a.m. May 27, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ITMN CAB SPWH DKS OPK YHOO 6:00 a.m. May 23, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: What Was Bad Is Good Again 7:54 p.m. May 22, 2014 - TheStreet.com
Additional Data on InterMune's Esbriet - Analyst Blog 5:05 p.m. May 21, 2014 - Zacks.com
Biotech Stock Roundup: Celldex, Incyte Tie Up with Big Pharma for Immuno-Oncology - Analyst Blog 9:22 a.m. May 21, 2014 - Zacks.com
InterMune Up on Esbriet Data Presentation - Analyst Blog 4:30 p.m. May 20, 2014 - Zacks.com
InterMune Offers Added Pirfenidone Data in Idiopathic Pulmonary Fibrosis, Says Endpoint Was Met with Statistical Significance in Capacity 2 4:03 p.m. May 20, 2014 - benzinga.com
InterMune (ITMN) Jumps: Stock Moves 13.4% Higher - Tale of the Tape 9:25 a.m. May 20, 2014 - Zacks.com
Why InterMune (ITMN) Stock Surged to a One-Year High Today 2:16 p.m. May 19, 2014 - TheStreet.com
Jim Cramer's Stop Trading: InterMune Shoots Higher, Zillow Could Too 11:15 a.m. May 19, 2014 - TheStreet.com
UPDATE: Investors Bullish On InterMune After Leerlink Upgrade 10:50 a.m. May 19, 2014 - benzinga.com
InterMune Higher on Superior Lung Drug Data, FDA Resubmission Next 10:39 a.m. May 19, 2014 - TheStreet.com
Benzinga's Volume Movers 9:27 a.m. May 19, 2014 - benzinga.com
Will This Analyst Upgrade Help InterMune (ITMN) Stock Today? 9:20 a.m. May 19, 2014 - TheStreet.com
Morning Market Movers 8:45 a.m. May 19, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:08 a.m. May 19, 2014 - benzinga.com
Pirfenidone Phase 3 achieves primary endpoint 10:53 p.m. May 18, 2014 - Seeking Alpha
Lung Drug Data Showdown: InterMune vs. Boehringer Ingelheim 5:05 p.m. May 18, 2014 - TheStreet.com

Critical Alerts For Macy's, Western Digital, InterMune, Merck, and Time Warner Released By InvestorsObserver 9:31 a.m. May 28, 2014 - PR Newswire - PRF
InterMune Announces Resubmission Of NDA For Pirfenidone For The Treatment Of Patients With IPF 7:00 a.m. May 27, 2014 - PR Newswire - PRF
Study Results, Extension of Supply Agreements, Drug Designations, Senior Level Appointments, and Upcoming Events - Analyst Notes on InterMune, Actavis, Bristol-Myers, AbbVie and Illumina 8:30 a.m. May 22, 2014 - PR Newswire - PRF
InterMune Announces Additional Pirfenidone Data in Idiopathic Pulmonary Fibrosis 5:00 p.m. May 20, 2014 - PR Newswire - PRF
Morning Coverage of Equities Reaching New Highs -- Research on InterMune, Zillow, ICICI Bank, and Zendesk 11:14 a.m. May 20, 2014 - PR Newswire - PRF
Phase 3 ASCEND Study of Pirfenidone in Idiopathic Pulmonary Fibrosis Presented at American Thoracic Society (ATS) and Published in New England Journal of Medicine 5:02 p.m. May 18, 2014 - PR Newswire - PRF
IDIOPATHIC PULMONARY FIBROSIS PATIENTS TO HAVE EXPANDED ACCESS TO THERAPY 8:12 a.m. May 16, 2014 - GlobeNewswire
InterMune Announces Expanded Access Program for Pirfenidone to Treat Idiopathic Pulmonary Fibrosis (IPF) in the United States 8:00 a.m. May 16, 2014 - PR Newswire - PRF
InterMune Announces Upcoming Data Presentations at 2014 American Thoracic Society Meeting 8:00 a.m. May 12, 2014 - PR Newswire - PRF
InterMune Reports First Quarter 2014 Financial Results, Clinical Development and Business Highlights 4:01 p.m. May 1, 2014 - PR Newswire - PRF
InterMune To Release First Quarter Financial Results On May 1 8:00 a.m. April 23, 2014 - PR Newswire - PRF
Approved Equities, Voluntary Recall, and New Product Launches - Analyst Notes on Baxter, Agilent, InterMune, Intuitive Surgical, and Mindray 8:00 a.m. March 14, 2014 - PR Newswire - PRF
InterMune Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock 7:20 p.m. March 13, 2014 - PR Newswire - PRF
InterMune Announces Proposed Public Offering of Common Stock 4:02 p.m. March 12, 2014 - PR Newswire - PRF
Top Gainers under the Lens: Advanced Micro Devices, Big Lots, InterMune, and Palo Alto Networks 1:38 p.m. March 10, 2014 - PR Newswire - PRF
Cannabis & Biotech Advancers Forging Ahead - Company Contracts With One of The Oldest Marijuana Dispensaries in California 9:05 a.m. March 10, 2014 - PR Newswire - PRF
Critical Alerts For InterMune, Infinity Pharmaceuticals, Zulily, Intrexon, and Polypore International Released By InvestorsObserver 10:31 a.m. Feb. 26, 2014 - PR Newswire - PRF
Consensus Earnings Forecast for BlackBerry, AT&T, Micron, InterMune, RF Micro Devices, and Coca-Cola 10:00 a.m. Feb. 26, 2014 - PR Newswire - PRF
Office Depot Offers Disappointing Outlook; InterMune Soars 170% to Record High on Phase 3 Test Results 1:25 a.m. Feb. 26, 2014 - ACCESSWIRE
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF) 8:00 a.m. Feb. 25, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Los Cabos Aims High: Luxury Tourism Plans for 2036

Aiming for the Stars: Los Cabos' 2036 Tourism Vision When you talk about a place like Los Cabos, it's like watching someone polish a gem that's already gleaming. They've spent the past decade ramping up visitation, connectivity, and their tourism value, and now they're eyeing a bold new horizon. By 2036, they're not just hoping to lure in the good ol' luxury traveler. No,...

Fannie Mae Q3 2026 Earnings Surpass Expectations

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Blade and Bow Drops Rare 30-Year-Old Cask Strength Expression

Turning Heads with a Rich Pour Forget watering down—Blade and Bow's latest masterpiece, the 30-Year-Old Cask Strength Kentucky Straight Bourbon Whiskey, is all about power. This new offering hasn't seen a drop of water since it left the barrel, clocking in at a punchy 164.2 proof. That's right, folks, they haven't pulled any punches this time. Heading into November,...

Coffee Bean Brews Up Nostalgia with Tiramisu Treats

Pouring Old Favorites: The Tiramisu Return When the aromas of coffee and nostalgia waft through the air, it's often a sign that The Coffee Bean & Tea Leaf® is brewing something special. This year, they've decided to double down on the holiday cheer by reintroducing their wildly popular Tiramisu beverage. This ain't just your run-of-the-mill coffee drink—it's a full-on...

Ballard’s HPU Agile-H Poised to Transform Portable Energy

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Infection Control Market Set for Explosive Growth by 2031

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Chesapeake Utilities Sets Stage for Q3 Earnings Review

Cashing In on Chesapeake's Dynamic Playbook Come November 6, 2026, at the ungodly hour of 8:30 a.m. ET, Chesapeake Utilities Corporation (NYSE: CPK) is opening the curtains on their third-quarter financial exploits. Now, these conference calls can be a real chess match, revealing just how the company’s pieces are positioned in this energy game. Buckle up, because the...

York Space Systems Faces Turbulence Amid Investor Lawsuit

York's Shaky Strategy Under the Microscope How do you go from sky-high ambitions to a grinding halt in a matter of weeks? This ain’t your typical Wall Street plot twist—it involves York Space Systems, or NYSE:YSS. These guys promised dominance in the Space Development Agency’s Transport Layer program, only to have their shooting star come crashing down. And now,...

Review Insurance Coverage After Major Life Changes

Why Life Changes Demand an Insurance Review The nitty-gritty of life doesn't sit still—marriages, babies, job changes, and home deals or steals each bring their own clutter to the table. One thing's for sure: when your life shifts, your insurance ought to keep pace. Insurance Agent Nick Hogan drops the dime in the latest HelloNation article, laying it bare why...